1457966-76-5

Basic information

• Product Name: N-(1-benzyl-2-butyl-1H-imidazo[4,5-c]pyridin-4-yl)butyramide
• CAS NO: 1457966-76-5
• Molecular Weight: 350.464
• Mol File: 1457966-76-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: N-(1-benzyl-2-butyl-1H-imidazo[4,5-c]pyridin-4-yl)butyramide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(1-benzyl-2-butyl-1H-imidazo[4,5-c]pyridin-4-yl)butyramide(1457966-76-5)
• EPA Substance Registry System: N-(1-benzyl-2-butyl-1H-imidazo[4,5-c]pyridin-4-yl)butyramide(1457966-76-5)

Safety Data

• Hazardous Substances Data: 1457966-76-5(Hazardous Substances Data)

Upstream product

• 1457966-66-3 1-benzyl-2-butyl-1H-imidazo[4,5-c]pyridine 5-oxide 
• 1457966-65-2 1-benzyl-2-butyl-1H-imidazo[4,5-c]pyridine 
• 57806-32-3 N⁴-benzylpyridine-3,4-diamine 
• 100306-70-5 4-(benzylamino)-3-nitropyridine 
• 1457966-67-4 1-benzyl-2-butyl-1H-imidazo[4,5-c]pyridin-4-amine 
• 141-75-3 butyryl chloride 
• 100-46-9 benzylamine 
• 13091-23-1 4-chloro-3-nitropyridine 

Relevant articles and documents

TOLL-LIKE RECEPTOR AGONISTS

Compounds described herein can be used for therapeutic purposes. The compounds can be TLR agonists, such as TLR7 or TLR8 agonists. The compounds can be included in pharmaceutical compositions and used for therapies were being a TLR agonist is useful. The pharmaceutical compositions can include any ingredients, such as carries, diluents, excipients, fillers or the like that are common in pharmaceutical compositions. The compounds can be those illustrated or described herein as well as derivatives thereof, prodrugs thereof, salts thereof, or stereoisomers thereof, or having any chirality at any chiral center, or tautomer, polymorph, solvate, or combinations thereof. As such, the compounds can be used as adjuvants in vaccines, as well as for other therapeutic purposes described herein.